Back
Global Payments 10K Form
Buy
70
GPN
Global Payments
Last Price:
129.42
Seasonality Move:
7.73%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2020-08-03 | 10Q | GPN/Global Payments Quarterly |
2020-05-06 | 10Q | GPN/Global Payments Quarterly |
2020-02-21 | 10K | GPN/Global Payments Annual |
2019-10-31 | 10Q | GPN/Global Payments Quarterly |
2019-07-30 | 10Q | GPN/Global Payments Quarterly |
2019-05-02 | 10Q | GPN/Global Payments Quarterly |
Receive GPN News And Ratings
See the #1 stock for the next 7 days that we like better than GPN
GPN Financial Statistics
Sales & Book Value
Annual Sales: | $8.98B |
---|---|
Cash Flow: | $396.15M |
Price / Cash Flow: | 21.73 |
Annual Sales: | $85.29 |
Price / Book: | 1.52 |
Profitability
EPS (TTM): | 3.00000 |
---|---|
Net Income (TTM): | $802.87M |
Gross Margin: | $5.2B |
Return on Equity: | 3.55% |
Return on Assets: | 1.75% |
Global Payments Earnings Forecast
Key Global Payments Financial Ratios
- The Gross Profit Margin over the past 23 years for GPN is 57.90%.
- The Selling, General & Administrative Expenses for GPN have been equal to 39.27% of Gross Profit Margin.
- The Research & Development expenses have been 0.00% of Revenue.
- The Interest Expense is 403.11% of Operating Income.
- The Net Earning history of GPN is 1.24% of Total Revenues.
- Per Share Earnings over the last 23 years have been positive in 13 years.
Global Payments Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NYSE |
---|---|
Industry: | Specialty Business Services |
Sector: | Industrials |
Current Symbol: | GPN |
CUSIP: | 37940X |
Website: | globalpaymentsinc.com |
Debt
Debt-to-Equity Ratio: | 0.79 |
---|---|
Current Ratio: | 1.08 |
Quick Ratio: | 0.6 |
Price-to-Earnings
Trailing P/E Ratio: | 323.3 |
---|---|
Forward P/E Ratio: | 10.92 |
GPN Technical Analysis vs Fundamental Analysis
Buy
70
Global Payments (GPN)
is a Buy
Is Global Payments a Buy or a Sell?
-
Global Payments stock is rated a Buy
The current Global Payments [GPN] share price is $129.32. The Score for GPN is 70, which is 40% above its historic median score of 50, and infers lower risk than normal.